Efficacy of donor screening for hepatitis C antibodies in preventing hepatitis C infection in multiply transfused patients
Brink, N.S.; Mills, W.; Chopra, R.; Garson, J.A.; Perrons, C.J.; Deaville, R.C.; Waite, J.; Goldstone, A.H.; Linch, D.C.; Tedder, R.S.
Transfusion Medicine 3(4): 291-294
1993
ISSN/ISBN: 0958-7578 DOI: 10.1111/j.1365-3148.1993.tb00064.x
Accession: 062302085
PDF emailed within 0-6 h: $19.90
Related References
Nelson, K.E.; Ahmed, F.; Stambolis, V.; Ness, P.M.; Yawn, D.; Mcallister, H. 1995: Incident hepatitis C virus and hepatitis B virus infections in transfused cardiac surgery patients Infection rates during different methods of donor screening NATIONAL INSTITUTES OF HEALTH NIH Consensus Development Conference on Infectious Disease Testing for Blood Transfusions 67-69Mele, A.; Sagliocca, L.; Palumbo, F.; Novaco, F.; Moiraghi, A.; Galanti, C.; Bernacchia, R.; Pasquini, P. 1993: Efficacy of blood screening of donors for antibodies to hepatitis C virus in preventing post-transfusion nonA, nonB hepatitis Journal of Public Health Medicine 15(4): 367
Waffarn, F.; Lerner, M.; Naglie, R.; Teo, L.; Baughman, P.; Ocariz, J. 1991: Hepatitis c screening in multiply transfused neonates Pediatric Research 29(4 Part 2): 270A
Lemon, S.M.; Becherer, P.R.; Wang, J.G.; White, G.C.; Lesesne, H.; Janco, R.L.; Hanna, W.T.; Davis, C.; Johnson, C.A.; Poon, M.C. 1991: Hepatitis delta infection among multiply-transfused hemophiliacs Progress in Clinical and Biological Research 364: 351-360
Xia, G-liang.; Gong, J.; Wang, J-jie.; Meng, Z-da.; Jia, Z-yuan.; Cao, H-lin.; Liu, C-bai. 2003: Efficacy of recombinant hepatitis B vaccine and low-dose hepatitis B immune globulin in preventing mother-infant transmission of hepatitis B virus infection Zhonghua Liu Xing Bing Xue Za Zhi 24(5): 362-365
Bocşan, I.S.; Neamţu, A.; Rădulescu, A.; Rafiroiu, C.; Suteu, O.; Pascu, O.; Vlăduţiu, D.; Neamţu, S.; Cucuianu, A.; State, D. 1995: The markers of hepatitis B, C and D viral infection in multiply transfused patients Bacteriologia Virusologia Parazitologia Epidemiologia 40(2): 109-113
Papaevangelou, V.; Spanou, E.; Kattamis, C.; Hadziyannis, S. 1997: GBV-C infection in multiply transfused thalassemia patients with chronic non A-E hepatitis Journal of Hepatology 26(Suppl 1): 91
Takano, S.; Omata, M.; Ohto, M.; Nakamura, K. 1993: Prospective assessment of donor blood screening for antibody to hepatitis C virus and high-titer antibody to hepatitis B core antigen as a means of preventing post-transfusion hepatitis Gastroenterologia Japonica 28 Suppl. 5: 84-87
Beeby, P.J.; Spencer, J.D.; Cossart, Y.E. 2001: Risk of hepatitis C virus infection in multiply transfused premature neonates Journal of Paediatrics and Child Health 37(3): 244-246
Alkindi, S.; Al-Umairi, N.; Jaju, S.; Pathare, A. 2019: Prevalence of Hepatitis B, Hepatitis C, and HIV in Multiply Transfused Sickle Cell Disease Patients from Oman Mediterranean Journal of Hematology and Infectious Diseases 11(1): E2019058
Poovorawan, Y.; Theamboonlers, A.; Chongsrisawat, V.; Seksarn, P.; Jarvis, L.; Simmonds, P. 1998: High prevalence of hepatitis G virus infection in multiply transfused children with thalassaemia Journal of Gastroenterology and Hepatology 13(3): 253-256
Hoyos, M.; Sarrión, J.V.; Pérez-Castellanos, T.; Prieto, M.; Marty, M.L.; Garrigues, V.; Berenguer, J. 1989: Prospective assessment of donor blood screening for antibody to hepatitis B core antigen as a means of preventing posttransfusion non-A, non-B, hepatitis Hepatology 9(3): 449-451
Ueda, Y.; Marusawa, H.; Kaido, T.; Ogura, Y.; Ogawa, K.; Yoshizawa, A.; Hata, K.; Fujimoto, Y.; Nishijima, N.; Chiba, T.; Uemoto, S. 2012: Efficacy and safety of prophylaxis with entecavir and hepatitis B immunoglobulin in preventing hepatitis B recurrence after living-donor liver transplantation Hepatology Research: the Official Journal of the Japan Society of Hepatology 43(1): 67-71
Takano, S.; Nakamura, K.; Kawai, S.; Yokosuka, O.; Satomura, Y.; Omata, M. 1996: Prospective assessment of donor blood screening for antibody to hepatitis C virus by first- and second-generation assays as a means of preventing posttransfusion hepatitis Hepatology 23(4): 708-712
Ebeling, F. 1991: Alanine aminotransferase, gamma-glutamyltransferase, antibodies to hepatitis B core antigen and antibodies to hepatitis C virus in blood donor screening. a prospective study in Finland Vox Sanguinis 60(4): 219-224
Ebeling, F. 1991: Alamine aminotransferase, gamma-glutamyltransferase, antibodies to hepatitis B core antigen and antibodies to hepatitis C virus in blood donor screening : a prospective study in Finland Vox Sanguinis (Basel 1956) 60(4): 219-224
Feitelson, M.A.; Taddei, M.G.; Ballas, S.K. 1996: Evidence for underlying hepatitis B virus infection among multiply transfused patients with sickle cell anemia Blood 88(10 Suppl 1 Part 1-2): 527A
Telfer, P.T.; Whitby, K.; Garson, J.A.; Hoffbrand, A.V.; Wonke, B. 1995: Alpha interferon alone and in combination with ribavirin for hepatitis C virus infection in multiply transfused thalassaemic patients Blood 86(10 Suppl 1): 484A
Ogata, N.; Funada, H.; Aoyagi, Y. 2011: Indications and efficacy of hepatitis B vaccines (HB vaccines) and hepatitis B immune globulin (HBIG): current situations and problems of hepatitis B virus (HBV) infection-preventing strategies in Japan Nihon Rinsho. Japanese Journal of Clinical Medicine 69 Suppl. 4: 408-416
Telfer, P.T.; Whitby, K.; Grant, P.; Garson, J.A.; Hoffbrand, A.V.; Wonke, B. 1996: Combination therapy with interferon alpha and ribavirin for hepatitis C virus infection in multiply transfused thalassaemic patients Blood 88(10 Suppl 1 Part 1-2): 527A